These factors contribute to the over 35% of patients with T2D who discontinue GLP1 RA use at one year
ABCB4 variants were associated with ICP (75%) and chronic liver disease (71.7%), with more severe genotypes correlating with an earlier onset
A lot of issues are unrelated to the safety of the peptides themselves [and related to] how they are used. This includes stacking multiple peptides, incorrect dosing, and the lack of appropriate monitoring, like bloodwork or imaging done under a doctors supervision
A Novo Nordisk representative recently visited his pharmacy with information on the drug, which is standard procedure ahead of a new drug coming on the market
The researchers discovered that these patients exhibited highly depleted peripheral serotonin levels, a hallmark recently identified in Long COVID cohorts as a driver of severe fatigue
Wegovy Wegovy (semaglutide) is an injectable GLP-1 receptor agonist given once weekly